EveryIntel
Live data

Pharma & Biotech

Drug-development and regulatory intelligence from public registries: clinical-trial activity by phase, and U.S. FDA drug enforcement reports (recalls) by severity.

Request Pharma intelligenceMethodology

Coverage today

Live: ClinicalTrials.gov study activity by phase and country; FDA drug recall (enforcement) counts. EMA and other regulators are being added.

Live series
60
Observations
273
Last collected
28 h ago

Scope of the sector

  • Drug pipelines
  • Clinical trials
  • Approvals
  • Recalls
  • Regulatory change
  • Patents
  • Licensing
  • M&A
  • Manufacturing

The scope EveryIntel is building toward. Only the datasets below are collected today.

Recruiting clinical studies by phase (global)

Early phase 1

987

as of 28 Sept 2026

Phase 1

6,319

as of 28 Sept 2026

Phase 2

10,236

as of 28 Sept 2026

Phase 3

4,147

as of 28 Sept 2026

Phase 4

2,259

as of 28 Sept 2026

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Studies spanning two phases are counted in each.

FDA drug enforcement reports (recalls) by classification

0102030Sept 2023Jun 2024Mar 2025Nov 2025Aug 2026
FDA Class I drug enforcement reports per month
MonthClass IClass IIClass III
Aug 20268414
Jul 202641016
Jun 20263656
May 20262379
Apr 20261926
Mar 20264534
Feb 20263403
Jan 20262465
Dec 20251538
Nov 20252737
Oct 2025210114
Sept 20257551
Aug 20250472
Jul 20255587
Jun 20259192
May 20251570
Apr 20254885
Mar 20255401

Source: U.S. Food and Drug Administration, openFDA. Class I: reasonable probability of serious adverse health consequences. Complete months only. Do not rely on openFDA to make decisions regarding medical care.

Pharma & Biotech

Research

No findings have been published for this sector yet. They appear as collectors detect meaningful changes.

Datasets and collectors

  • Clinical research activity by country and phasePublic

    Daily snapshots of recruiting studies in ClinicalTrials.gov by country (54 countries across every region) and by phase.

    Geography: global (US, CA, MX, BR, AR, CL, CO, PE, GB, DE, FR, IT, ES, NL, BE, CH, SE, DK, NO, PL, AT, GR, TR, RU, UA, EG, MA, NG, GH, KE, UG, TZ, ET, ZA, SA, AE, QA, IL, IN, PK, BD, CN, JP, KR, TW, HK, SG, TH, VN, MY, ID, PH, AU, NZ) · Frequency: Daily

  • FDA drug enforcement reports by classPublic

    Monthly counts of U.S. FDA drug recall enforcement reports by classification (Class I, II, III), complete months only.

    Geography: country (US) · Frequency: Weekly

  • ClinicalTrials.gov recruiting activity by country and phase

    Daily snapshot · Last successful run: 28 h ago

  • FDA drug enforcement reports (monthly counts by class)

    Weekly · Last successful run: 28 h ago

Need pharma & biotech intelligence for a specific market, company or country?

Requests are reviewed by a person for feasibility, sources, rights and cost. Nothing is promised until it has been assessed.

Request intelligence